Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000796877 | SCV000936409 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003258973 | SCV003983516 | uncertain significance | Inborn genetic diseases | 2023-05-24 | criteria provided, single submitter | clinical testing | The c.1609C>T (p.R537C) alteration is located in exon 9 (coding exon 8) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 1609, causing the arginine (R) at amino acid position 537 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |